chr2-169204113-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_004525.3(LRP2):c.7874G>A(p.Gly2625Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000214 in 1,614,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2625R) has been classified as Uncertain significance.
Frequency
Consequence
NM_004525.3 missense
Scores
Clinical Significance
Conservation
Publications
- Donnai-Barrow syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Stickler syndromeInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRP2 | NM_004525.3 | c.7874G>A | p.Gly2625Asp | missense_variant | Exon 42 of 79 | ENST00000649046.1 | NP_004516.2 | |
| LRP2 | XM_011511183.4 | c.7874G>A | p.Gly2625Asp | missense_variant | Exon 42 of 78 | XP_011509485.1 | ||
| LRP2 | XM_047444340.1 | c.6950G>A | p.Gly2317Asp | missense_variant | Exon 42 of 79 | XP_047300296.1 | ||
| LRP2 | XM_011511184.3 | c.5585G>A | p.Gly1862Asp | missense_variant | Exon 27 of 64 | XP_011509486.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LRP2 | ENST00000649046.1 | c.7874G>A | p.Gly2625Asp | missense_variant | Exon 42 of 79 | NM_004525.3 | ENSP00000496870.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000477 AC: 12AN: 251416 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.000228 AC: 333AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.000227 AC XY: 165AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74332 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 2625 of the LRP2 protein (p.Gly2625Asp). This variant is present in population databases (rs745794041, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with LRP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 445880). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LRP2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Donnai-Barrow syndrome Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at